NVTA - Invitae Corporation
NYSE
->
Healthcare
->
Diagnostics & Research
San Francisco,
United States
Type: Equity
NVTA price evolution
NVTA
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $168.11 | $233.27 | $171.23 | $267.52 |
| Short term investments | $96.57 | $102.38 | $217.5 | $289.61 |
| Net receivables | $82.51 | $85.61 | $85.59 | $96.15 |
| Inventory | $21.63 | $20.81 | $19.07 | $30.39 |
| Total current assets | $378.4 | $451.23 | $504.27 | $693.13 |
| Long term investments | ||||
| Property, plant & equipment | $127.08 | $166.81 | $173.5 | $215.29 |
| Goodwill & intangible assets | $873.92 | $981.89 | $1012.55 | |
| Total noncurrent assets | $156.72 | $1071.81 | $1187.39 | $1260.99 |
| Total investments | $96.57 | $102.38 | $217.5 | $289.61 |
| Total assets | $535.12 | $1523.04 | $1691.66 | $1954.12 |
| Current liabilities | ||||
| Accounts payable | $25.18 | $23.07 | $11.9 | $13.98 |
| Deferred revenue | ||||
| Short long term debt | $48.51 | $20.95 | $93.15 | $19.72 |
| Total current liabilities | $158.42 | $151.97 | $190.18 | $108.09 |
| Long term debt | $1459.87 | $1561.42 | $1526.68 | $1596.9 |
| Total noncurrent liabilities | $1460.1 | $1571.86 | $1538.14 | $1744.19 |
| Total debt | $1508.38 | $1582.37 | $1619.83 | $1751 |
| Total liabilities | $1618.52 | $1723.83 | $1728.32 | $1852.28 |
| Shareholders' equity | ||||
| Retained earnings | -$6169.94 | -$5227.84 | -$5021.32 | -$4829.14 |
| Other shareholder equity | $25.38 | $8.91 | -$0.11 | -$0.08 |
| Total shareholder equity | -$1083.4 | -$200.79 | -$36.66 | $101.84 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $267.52 | $933.52 | $131.48 | $157.57 |
| Short term investments | $289.61 | $122.12 | $229.19 | $240.44 |
| Net receivables | $96.15 | $66.23 | $47.72 | $32.54 |
| Inventory | $30.39 | $33.52 | $32.03 | $6.65 |
| Total current assets | $693.13 | $1178.81 | $453.93 | $442.4 |
| Long term investments | ||||
| Property, plant & equipment | $215.29 | $235.88 | $111.21 | $74.39 |
| Goodwill & intangible assets | $1012.55 | $3471.05 | $2845.47 | $251.95 |
| Total noncurrent assets | $1260.99 | $3740.76 | $2976.55 | $339.2 |
| Total investments | $289.61 | $122.12 | $229.19 | $240.44 |
| Total assets | $1954.12 | $4919.57 | $3430.49 | $781.6 |
| Current liabilities | ||||
| Accounts payable | $13.98 | $21.13 | $25.2 | $10.32 |
| Deferred revenue | ||||
| Short long term debt | $19.72 | $16.52 | $10.48 | $6.72 |
| Total current liabilities | $108.09 | $144.09 | $121.75 | $81.86 |
| Long term debt | $1596.9 | $1707.58 | $439.65 | $312.1 |
| Total noncurrent liabilities | $1744.19 | $1797.07 | $1332.45 | $320.1 |
| Total debt | $1751 | $1724.1 | $450.14 | $318.83 |
| Total liabilities | $1852.28 | $1941.17 | $1454.19 | $401.96 |
| Shareholders' equity | ||||
| Retained earnings | -$4829.14 | -$1722.85 | -$1360.85 | -$758.68 |
| Other shareholder equity | -$0.08 | -$0.01 | $0 | -$0.01 |
| Total shareholder equity | $101.84 | $2978.4 | $1976.29 | $379.64 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $121.24 | $120.53 | $117.36 | $122.45 |
| Cost of revenue | $82.19 | $87.47 | $88.44 | $92.84 |
| Gross Profit | $39.05 | $33.06 | $28.91 | $29.61 |
| Operating activities | ||||
| Research & development | $58.34 | $63.82 | $61.98 | $71.53 |
| Selling, general & administrative | $83.62 | $114.7 | $89.75 | $90.04 |
| Total operating expenses | $1019.24 | $259.52 | $204.28 | $124.5 |
| Operating income | -$980.19 | -$226.46 | -$175.37 | -$94.89 |
| Income from continuing operations | ||||
| EBIT | -$942.43 | -$201.41 | -$181.65 | -$90.57 |
| Income tax expense | -$6.17 | -$0.92 | -$0.96 | -$5.35 |
| Interest expense | $5.85 | $6.02 | $11.5 | $14.6 |
| Net income | ||||
| Net income | -$942.11 | -$206.51 | -$192.18 | -$99.82 |
| Income (for common shares) | -$942.11 | -$206.51 | -$192.18 | -$99.82 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $516.3 | $460.45 | $279.6 | $216.82 |
| Cost of revenue | $417.26 | $348.67 | $198.28 | $118.1 |
| Gross Profit | $99.05 | $111.78 | $81.32 | $98.72 |
| Operating activities | ||||
| Research & development | $402.09 | $416.09 | $240.6 | $141.53 |
| Selling, general & administrative | $411.19 | $473.98 | $492.89 | $201.31 |
| Total operating expenses | $3219.31 | $890.07 | $733.5 | $342.83 |
| Operating income | -$3120.26 | -$778.29 | -$652.17 | -$244.11 |
| Income from continuing operations | ||||
| EBIT | -$3094.45 | -$365.96 | -$684.5 | -$248 |
| Income tax expense | -$44.9 | -$36.86 | -$112.1 | -$18.45 |
| Interest expense | $56.75 | $49.9 | $29.77 | $12.41 |
| Net income | ||||
| Net income | -$3106.29 | -$379.01 | -$602.17 | -$241.97 |
| Income (for common shares) | -$3106.29 | -$379.01 | -$602.17 | -$241.97 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | -$942.11 | -$206.51 | -$192.18 | -$99.82 |
| Operating activities | ||||
| Depreciation | $34.37 | $37.27 | $38.07 | $40.75 |
| Business acquisitions & disposals | $44.55 | |||
| Stock-based compensation | $26.13 | $31.19 | $30.02 | $38.44 |
| Total cash flows from operations | -$66.89 | -$54.91 | -$34.4 | -$82.03 |
| Investing activities | ||||
| Capital expenditures | -$1.93 | -$1.08 | -$1.32 | -$4.92 |
| Investments | $7.05 | $117.15 | $75.2 | $82.26 |
| Total cash flows from investing | $5.12 | $116.06 | $73.88 | $121.89 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.06 | $2.17 | $0 | $1.89 |
| Net borrowings | $0.73 | -$1.29 | -$134.3 | -$1.23 |
| Total cash flows from financing | -$3.38 | $0.88 | -$135.77 | $0.6 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$65.16 | $62.03 | -$96.29 | $40.46 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$3106.29 | -$379.01 | -$602.17 | -$241.97 |
| Operating activities | ||||
| Depreciation | $152.31 | $80.47 | $39.05 | $16.21 |
| Business acquisitions & disposals | $44.55 | -$247.4 | -$383.75 | -$33.85 |
| Stock-based compensation | $207.73 | $189.6 | $249.77 | $75.95 |
| Total cash flows from operations | -$492.96 | -$559.82 | -$298.5 | -$145.05 |
| Investing activities | ||||
| Capital expenditures | -$53.31 | -$54.72 | -$22.86 | -$20.05 |
| Investments | -$166.05 | $99.34 | $10.06 | -$226.42 |
| Total cash flows from investing | -$174.8 | -$204.08 | -$400.58 | -$280.31 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $17.82 | $458.03 | $547.89 | $213.49 |
| Net borrowings | -$5.41 | $1112.67 | $129.21 | $252.19 |
| Total cash flows from financing | $1.76 | $1565.94 | $672.99 | $464.77 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$666.01 | $802.04 | -$26.09 | $39.41 |
News
Fundamentals
| Market cap | $773.53K |
|---|---|
| Enterprise value | $1.34B |
| Shares outstanding | 286.49M |
| Revenue | $481.58M |
|---|---|
| EBITDA | -$1.27B |
| EBIT | -$1.42B |
| Net Income | -$1.44B |
| Revenue Q/Q | -9.21% |
| Revenue Y/Y | -7.38% |
| P/E ratio | -0.00 |
|---|---|
| EV/Sales | 2.78 |
| EV/EBITDA | -1.06 |
| EV/EBIT | -0.95 |
| P/S ratio | 0.00 |
| P/B ratio | -0.00 |
| Book/Share | -3.87 |
| Cash/Share | 0.59 |
| EPS | -$5.03 |
|---|---|
| ROA | -101.03% |
| ROE | 472.72% |
| Debt/Equity | 18.19 |
|---|---|
| Net debt/EBITDA | -1.15 |
| Current ratio | 2.39 |
| Quick ratio | 2.25 |